Branded

Branded

12/21/2010 - 5:30pm

Biogen acquires rights to neuro disease programs

In a deal that will bolster its drug development capabilities, Biogen Idec has acquired a subsidiary of Swiss-based Neurimmune Holding AG.

12/21/2010 - 4:58pm

Abbott, EpiTherapeutics ink 3-year licensing agreement

Abbott has made a pact with a biopharmaceutical company to develop new cancer treatments by making small-molecule inhibitors.

12/21/2010 - 4:28pm

URAC revises accreditation programs

A healthcare accrediting organization is revising three products in its Pharmacy Quality Management suite of programs.

12/21/2010 - 4:02pm

Pfizer to recall lot of Lipitor

Pfizer on Monday announced that it intends to recall one lot — approximately 19,000 bottles — of Lipitor 40-mg tablets (atorvastatin calcium) distributed in the United States because of one customer’s report of an uncharacteristic odor related to the bottles in which these lots of Lipitor were packaged.

12/21/2010 - 1:18pm

AstraZeneca discontinues development of RSV drug

An Anglo-Swedish drug maker said it is discontinuing further development of a drug that is designed to prevent a respiratory virus that infects the lungs and breathing passages.

12/21/2010 - 12:05pm

Court blocks AstraZeneca's suits over Crestor

A judge recently blocked AstraZeneca from attempting to impede the development of generic versions of its popular cholesterol drug, according to published reports.

12/21/2010 - 11:20am

Novo Nordisk, Emisphere enter insulin deal

A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.

12/21/2010 - 11:11am

Lilly completes acquisition of Avid

One month after announcing it would acquire a leader in molecular imaging development, Eli Lilly announced it has completed its acquisition of Avid Radiopharmaceuticals.

12/20/2010 - 12:47pm

Lilly donates grant to Manchester College for pharmacy school

Manchester College has received a $35 million grant from the Lilly Endowment to launch a new school of pharmacy.

12/20/2010 - 10:18am

Valeant names interim CFO

Valeant Pharmaceuticals' former SVP and corporate controller has been appointed to the role of interim CFO.